Novartis Investigative Site

Taipei, ROC

0 studies enrolling now · 1 studies all time

What they study most

Chronic Hepatitis C Genotype-1 Relapse

Studies at this site

• Adaptive-design Dose Finding Study to Assess the Antiviral Efficacy and Safety of NIM811 Administered in Combination With Standard of Care (SOC) in Relapsed Hepatitis C Virus 1 (HCV-1) Infected Patients — Completed